← All peptides
Longevity & Anti-aging
Collagen & Skin
Research Chemical

Vesilute

Also known as: Vesilute, Vesilut

Vesilute is a short bioregulator peptide studied for effects on the microvasculature and skin around the eyes. It is associated with reducing periorbital puffiness and supporting capillary tone.

Last updated

Mechanism of Action

Vesilute belongs to the Khavinson family of short peptide bioregulators thought to act on tissue-specific gene expression. It is associated with vascular and connective-tissue regulation, particularly in the delicate periorbital region, supporting capillary integrity and microcirculation. By modulating fibroblast and endothelial activity it is proposed to reduce fluid stasis and improve local tissue resilience. As with other Cytomax-type peptides, the postulated mechanism centers on normalizing protein synthesis in target cells.

Half-life
Short, not precisely characterized
Administration Routes
topical, subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Supports periorbital microcirculation
  • May reduce under-eye puffiness
  • Promotes capillary and connective-tissue tone
  • Investigated for skin resilience around the eyes
  • Part of the short-peptide bioregulator family

Potential Side Effects

  • Possible local irritation
  • Limited human safety data
  • Unknown long-term effects

Common Dosing

For research use only: short bioregulator peptides are typically referenced in low microgram-range topical or subcutaneous research protocols; no validated human dosing exists. Not personal medical advice.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Pregnancy and breastfeeding
  • Known peptide hypersensitivity

No notable studies catalogued for Vesilute yet.

It is studied for its proposed effects on periorbital microcirculation and skin, including reducing under-eye puffiness and supporting capillary tone.

No. It is a research-chemical short peptide bioregulator without robust human clinical validation.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.